Total Funding
9
Total FundingSeries B raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Nephera is a development-stage medical device company focused on kidney function in congestive heart failure (CHF) patients.
Yair Feld: Founder
About the Company
Nephera (Israeli) a development-stage medical device company focused on kidney function in CHF patients. Nephera offers a treatment for acute heart failure patients by protecting kidney function through the modulation of sympathetic nerve activity. The company’s unique technology, in the exciting field of neurohormonal modulation, is based on
electrical stimulation of the urinary tract for controlled inhibition of renal sympathetic nerve activity. The clinical outcome is preserved renal function and enhanced diuretic therapy.
